Furthermore, quantitative data obtained from urine samples can be used to calculate the provisional mean daily intake if toxicokinetic data are available (see Sects
The good news for most people is that side effects are temporary
[12] Some patients report alterations in mood or libido (which can manifest as irritability, aggression, or changes in sex drive), as well as headache, fatigue, or changes in energy level
The British National Formulary (BNF) does not flag any clinically significant interactions between GLP-1 receptor agonists and proton pump inhibitors
Several studies have demonstrated that the GLP-1 receptor agonists such as extendin-4 and liraglutide can activate AMPK signalling in multiple tissues and cell types, including cardiomyocyte hyperglycaemic [20] or cardiac hypertrophy models [21], in rat INS-1 pancreatic beta cells [22], and in L6 myotubes, resulting in the sensitisation of insulin-stimulated glucose uptake [23]